Loss of p16 INK4A Expression and Homozygous CDKN2A Deletion Are Associated with Worse Outcome and Younger Age in Thymic Carcinomas-Reference-Cited by-同舟云学术

Loss of p16 INK4A Expression and Homozygous CDKN2A Deletion Are Associated with Worse Outcome and Younger Age in Thymic Carcinomas

Published:2017-05 Issue:5 Volume:12 Page:860-871
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Aesif Scott W.,Aubry Marie Christine,Yi Eunhee S.,Kloft-Nelson Sara M.,Jenkins Sarah M.,Spears Grant M.,Greipp Patricia T.,Sukov William R.,Roden Anja C.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. Clinical value of the WHO classification system of thymoma;Detterbeck;Ann Thorac Surg,2006

2. Thymic carcinoma: a cohort study of patients from the European Society of Thoracic Surgeons database;Ruffini;J Thorac Oncol,2014

3. Long-term survival after surgical treatment of thymic carcinoma: a retrospective analysis from the Chinese Alliance for Research of Thymoma database;Fu;Ann Surg Oncol,2016

4. Thymic carcinoma: outcomes after surgical resection;Okereke;Ann Thorac Surg,2012

5. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Thymomas and thymic carcinomas. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed March 1, 2016.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies;International Journal of Molecular Sciences;2024-09-03

2. Prevalence of S-methyl-5′-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer;American Journal of Surgical Pathology;2024-08-12

3. Deletion of cyclin dependent kinase inhibitor 2a gene as a marker of oropharyngeal carcinomas non-associated with human papillomavirus and its prognostic value;Medicni perspektivi;2024-06-28

4. Non-Mutational Key Features in the Biology of Thymomas;Cancers;2024-02-26

5. What Have We Learned from Molecularly Informed Clinical Trials on Thymomas and Thymic Carcinomas—Current Status and Future Directions?;Cancers;2024-01-18